A NOVEL GENETIC MARKER FOR INHERITED DISORDER OF THE HEART CONDUCTION SYSTEM
https://doi.org/10.15829/1560-4071-2015-10-14-16
Abstract
Aim. To study relation of mononucleotide polymorphism G>A of the gene SCN10A and development of inherited pathology of the heart conduction system.
Material and methods. Totally, 260 persons investigated with primary disorders of cardiac conduction (71 patient with atrioventricular conduction disorder, 84 patients with the Right His bundle branch conduction disorder and 105 — the Left) and 263 persons without any found cardiovascular diseases (controls). All patients underwent standard cardiological investigation, retrospective analysis of previous investigation data (if available), molecular genetic test of DNA.
Results. The obtained results showed statistically significant predominance of the widespread genotype GG gene SCN10A in the control group comparing to atrioventricular disorder patients and Right His bundle branch patients.
Conclusion. Homozygous genotype GG of the gene SCN10A plays protective role against development of idiopathic atrioventricular blocks and Right His bundle branch block.
About the Authors
S. Yu. Nikulina
Krasnoyarsk State Medical University named after Voyno-Yasenetsky
Russian Federation
Russian Federation
A. A. Chernova
Krasnoyarsk State Medical University named after Voyno-Yasenetsky
Russian Federation
Russian Federation
S. S. Tretyakova
Krasnoyarsk State Medical University named after Voyno-Yasenetsky
Russian Federation
Russian Federation
References
1. Anderson AG. Primary (genetically determined) cardiac conduction system diseases and its association with disturbances of sodium cannels function. Annals of Arhythmology 2005; 4(2): 50-5. Russian (А. Г. Андерсон. Первичные (генетически детерминированные) заболевания проводящей системы сердца и их взаимосвязь с нарушениями функции натриевого канала. Анналы аритмологии 2005; 4(2): 50-5).
2. Baruteau AE, Probst V, Abriel H. Inherited progressive cardiac conduction disorders. Curr. Opin. Cardiol. 2015. 30(1): 33-9.
3. Andreasen L, Nielsen JB, Darkner S, et al. Brugada syndrome risk loci seem protective against atrial fibrillation. Eur. J. Hum. Genet. 2014. 22(12): 1357-61.
4. Chambers JC, Zhao J, Terracciano CM, et al. Genetic variation in SCN10A influences cardiac conduction. Nat Genet. 2010; 42, 2: 149-52.
5. Jabbari J, Olesen MS, Yuan L.Common and Rare Variants in SCN10A Modulate the Risk of Atrial Fibrillation. Circ. Cardiovasc. Genet. 2015. 8(1): 64-73.
6. Behr ER, Savio-Galimberti E, Barc J, et al. Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study. Cardiovasc. Res. 2015. Feb 17. pii: cvv042.
7. Bezzina CR, Barc J, Mizusawa Y. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with highrisk of sudden cardiac death. Nat Genet. 2013; 45, 11: 1044-9.
8. Jeff JM, Ritchie MD, Denny JC, et al. Generalization of variants identified by genomewide association studies for electrocardiographic traits in African Americans. Ann. Hum. Genet. 2013; 77(4): 321-32.
9. Delaney JT, Muhammad R, Shi Y, et al. Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation. Europace. 2014.16(4): 485-90.
10. Fukuyama M, Ohno S, Makiyama T, et al. Novel SCN10A variants associated with Brugada syndrome. Europace. 2015 Apr 4. pii: euv078.
Review
For citations:
Nikulina S.Yu., Chernova A.A., Tretyakova S.S. A NOVEL GENETIC MARKER FOR INHERITED DISORDER OF THE HEART CONDUCTION SYSTEM. Russian Journal of Cardiology. 2015;(10):30-34. (In Russ.) https://doi.org/10.15829/1560-4071-2015-10-14-16
Views:
744
Email this article 